Our clinical obeservation indicated that the patient B showed low level of cytokines such as IL-6, MCP-3, MCP-1, IP-10 and IL-1α after treatment with LS, which hinted that LS could prevent COVID-19 into hyperinflammatory status. This evidence concerns the gene CXCL10 and COVID-19.